03:53 PM EST - BioSyent Inc. : released today a summary of its second quarter (Q2) 2013 financial results for the three months ending June 30. Q2 2013 sales were $1,786,685 increased by 47% versus Q2 2012. Q2 2013 Income Before Tax of $542,964 increased by 61% versus Q2 2012. Q2 2013 Tax Expense was $124,639 versus nil in Q2 2012. Q2 Net Income After Tax of $418,325 increased by 24% versus Q2 2012. BioSyent Inc.
shares V.RX are trading up $0.07 at $1.94.
